These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11282268)

  • 1. Pharmacokinetics of intravenously administered pefloxacin in the prostate; perspectives for its application in surgical prophylaxis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Stinios I; Chrisofos M; Giannopoulou M; Giamarellou H
    Int J Antimicrob Agents; 2001 Mar; 17(3):221-4. PubMed ID: 11282268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
    Wagenlehner FM; Lunz JC; Kees F; Wieland W; Naber KG
    J Chemother; 2006 Oct; 18(5):485-9. PubMed ID: 17127224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery.
    Gascón AR; Campo E; Olea E; Hernández RM; Calvo B; Errasti J; Pedraz JL
    Biopharm Drug Dispos; 2002 Oct; 23(7):293-300. PubMed ID: 12355580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentration level of latamoxef sodium (LMOX) in prostatic tissue].
    Takao M; Matsuzaki S; Ao T; Nagakura K; Fujioka T; Hata M; Nakamura H; Hayakawa M
    Hinyokika Kiyo; 1985 Mar; 31(3):539-43. PubMed ID: 2411116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of pefloxacin in plasma and tissue after administration as surgical prophylaxis.
    Jacoberger B; Ubeaud G; Freys G; Pottecher T; Jung L; Koffel JC
    Antimicrob Agents Chemother; 1998 Feb; 42(2):425-7. PubMed ID: 9527798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of pefloxacin in goats after intravenous or oral administration.
    Malik JK; Rao GS; Ramesh S; Muruganandan S; Tripathi HC; Shukla DC
    Vet Res Commun; 2002 Feb; 26(2):141-9. PubMed ID: 11922483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue penetration of pefloxacin plus metronidazole after administration as surgical prophylaxis in colorectal surgery.
    Gascón AR; Gutiérrez-Aragón G; Hernández RM; Errasti J; Pedraz JL
    Int J Clin Pharmacol Ther; 2003 Jun; 41(6):267-74. PubMed ID: 12816179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pefloxacin penetration into human necrotic pancreatic tissue.
    Bertazzoni Minelli E; Benini A; Muner A; Bassi C; Abbas H; Pederzoli P
    J Antimicrob Chemother; 1996 Aug; 38(2):237-43. PubMed ID: 8877537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of pefloxacin and its desmethyl metabolite into the uroepithelium after a 800-mg single oral dose in human patients.
    Moreau JL; Royer-Morrot MJ; Lozniewski A; Trackoen G; Delavault P; Royer RJ
    Eur J Clin Pharmacol; 1996; 49(5):401-5. PubMed ID: 8866637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Panou C; Adamakis I; Giamarellou H
    J Urol; 2001 Jan; 165(1):97-9. PubMed ID: 11125373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of pefloxacin in sheep.
    Moutafchieva R; Djouvinov D
    J Vet Pharmacol Ther; 1997 Oct; 20(5):405-7. PubMed ID: 9350263
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of pefloxacin in human prostatic tissue.
    Salpigides G; Pangalis A; Kouvelas D; Paradelis AG
    J Chemother; 1995 Nov; 7 Suppl 4():105-6. PubMed ID: 8904124
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on the concentration of cefminox sodium in serum and prostatic tissue].
    Sasagawa I
    Hinyokika Kiyo; 1990 Jun; 36(6):737-9. PubMed ID: 1700586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin.
    Kanellakopoulou K; Galanakis N; Giamarellos-Bourboulis EJ; Rifiotis C; Papakostas K; Andreopoulos A; Dounis E; Karagianakos P; Giamarellou H
    J Antimicrob Chemother; 2000 Aug; 46(2):311-4. PubMed ID: 10933660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion of tosufloxacin into prostatic tissue.
    Uchibayashi T; Hisazumi H; Kanayama J; Kumano K
    Chemotherapy; 1992; 38(3):150-4. PubMed ID: 1380905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of pefloxacin in the treatment of infected burn wounds].
    Iakovlev VP; Alekseev AA; Krutikov MG; Grishina IA; Izotova GN
    Antibiot Khimioter; 1996 Jun; 41(6):39-43. PubMed ID: 9054328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some pharmacokinetic parameters of pefloxacin in lactating goats.
    Abd El-Aty AM; Goudah A
    Vet Res Commun; 2002 Oct; 26(7):553-61. PubMed ID: 12416870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.
    Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P
    Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.